Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy

Clinical outcome of Taiwanese men with clinically localized prostate cancer post-radical prostatectomy: a comparison with other ethnic groups

(2009) Shu-pin Huang et al.   Aging Male

Association Analysis of Wnt Pathway Genes on Prostate-Specific Antigen Recurrence After Radical Prostatectomy

(2009) Shu-Pin Huang et al.   ANNALS OF SURGICAL ONCOLOGY

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

(2009) Toni K. Choueiri et al.   CANCER

Prognostic Significance of Prostate Cancer Susceptibility Variants on Prostate-Specific Antigen Recurrence after Radical Prostatectomy

(2009) S.-P. Huang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer

(2008) Robert W. Ross et al.   CANCER

Androgen receptor: role and novel therapeutic prospects in prostate cancer

(2008) Mary-Ellen Taplin   Expert Review of Anticancer Therapy

Inherited Variation in the Androgen Pathway Is Associated With the Efficacy of Androgen-Deprivation Therapy in Men With Prostate Cancer

(2008) Robert W. Ross et al.   JOURNAL OF CLINICAL ONCOLOGY

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

(2008) Y. Niu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mechanisms mediating androgen receptor reactivation after castration

(2008) Xin Yuan et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS